VOYA Investment Management
TVRD

VOYA Investment Management’s Tvardi Therapeutics TVRD Stock Holding History

VOYA Investment Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,608
Closed -$184K – 2916
2024
Q1 		$184K Buy
5,608
+1,583
+39% +$41K ﹤0.01% 2483
2023
Q4 		$108K Buy
4,025
+1,831
+83% +$75.8K ﹤0.01% 2738
2023
Q3 		$133K Buy
2,194
+668
+44% +$62.7K ﹤0.01% 2662
2023
Q2 		$155K Buy
1,526
+251
+20% +$34.6K ﹤0.01% 2669
2023
Q1 		$225K Hold
1,275
– – ﹤0.01% 2466
2022
Q4 		$493K Hold
1,275
– – ﹤0.01% 2046
2022
Q3 		$430K Buy
1,275
+135
+12% +$48.9K ﹤0.01% 2119
2022
Q2 		$375K Hold
1,140
– – ﹤0.01% 2017
2022
Q1 		$499K Buy
1,140
+672
+144% +$276K ﹤0.01% 1921
2021
Q4 		$205K Buy
468
+1
+0.2% +$502 ﹤0.01% 2500
2021
Q3 		$259K Hold
467
– – ﹤0.01% 2421
2021
Q2 		$240K Sell
467
-51
-10% -$32.3K ﹤0.01% 2499
2021
Q1 		$405K Sell
518
-5
-1% -$3.42K ﹤0.01% 2150
2020
Q4 		$285K Buy
523
+120
+30% +$62.9K ﹤0.01% 2224
2020
Q3 		$185K Hold
403
– – ﹤0.01% 2182
2020
Q2 		$248K Sell
403
-153
-28% -$84.5K ﹤0.01% 2059
2020
Q1 		$264K Buy
556
+26
+5% +$14.1K ﹤0.01% 1983
2019
Q4 		$307K Buy
530
+127
+32% +$89.1K ﹤0.01% 2168
2019
Q3 		$265K Hold
403
– – ﹤0.01% 2113
2019
Q2 		$312K Buy
403
+20
+5% +$14.1K ﹤0.01% 2068
2019
Q1 		$270K Hold
383
– – ﹤0.01% 2115
2018
Q4 		$179K Buy
383
+47
+14% +$30.3K ﹤0.01% 2254
2018
Q3 		$290K Buy
336
+37
+12% +$26.7K ﹤0.01% 2162
2018
Q2 		$206K Sell
299
-43
-13% -$21.9K ﹤0.01% 2348
2018
Q1 		$152K Hold
342
– – ﹤0.01% 2401
2017
Q4 		$151K Hold
342
– – ﹤0.01% 2426
2017
Q3 		$169K Hold
342
– – ﹤0.01% 2440
2017
Q2 		$190K Buy
342
+46
+16% +$29.2K ﹤0.01% 2426
2017
Q1 		$196K Hold
296
– – ﹤0.01% 2286
2016
Q4 		$99K Hold
296
– – ﹤0.01% 2455
2016
Q3 		$89 Hold
296
– – ﹤0.01% 2479
2016
Q2 		$51K Buy
+296
New +$64.4K ﹤0.01% 2545

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VOYA Investment Management's TVRD Position: Q2 2024 in Review

VOYA Investment Management sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 5,608 shares — an estimated $184K sold.

VOYA Investment Management first reported a position in TVRD in Q2 2016 and held it in 32 quarters. The position peaked at $499K in Q1 2022. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.

  • VOYA Investment Management reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 5,608 Tvardi Therapeutics shares in Q2 2024, an estimated $184K.
  • VOYA Investment Management first reported a position in Tvardi Therapeutics in Q2 2016 and held it in 32 quarters.
  • VOYA Investment Management's Tvardi Therapeutics position peaked at $499K in Q1 2022.
  • 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.